WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics (TM), today announced plans for its scientists to make poster presentations at the 37th annual meeting of the Society for Neuroscience (SFN). The SFN meeting will be held November 3-7, 2007 at the San Diego Convention Center.
